Bristol-Myers Tries to Boost Abilify
602585
Bristol-Myers announces new data for one of its top compounds.
595644
The British drugmaker looks to regain momentum this year.
151450
Pfizer&#39;s schizophrenia drug Geodon (ziprasidone HCI) has won new US Food and Drug Administration approval to treat bipolar mania, a condition characterized by unnatural highs that can lead to impulsive and dangerous behaviors.
468846
A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals Inc. pounced.
640990
Now might be a great time to load up on cutting-edge drug makers.
395583
A small biotechnology company on  Tuesday reported promising results from a clinical trial for a  new vaccine that could help people quit smoking.
384676
Psychological therapy can greatly boost the effectiveness of drugs in treating bipolar disorder, but these specialized talk therapies aren't as widely available as they should be, experts say.
640860
Science & environment: Biotechnology checks for bipolar depression and schizophrenia will soon be sold over the web
567241
Drug company Eli Lilly  has  encouraged primary care physicians to use Zyprexa, a powerful  drug for schizophrenia and bipolar disorder, in patients who  did not have either condition, the New York Times reported on  its Web site on Monday, citing internal Lilly marketing  materials.
642842
People going online seeking pills to relieve a variety of conditions are shipped a powerful anti-psychotic drug instead, an investigation by health officials reveals. By the Associated Press.
332083
Bristol-Myers Squibb Co. said on  Sunday its experimental drug for rheumatoid arthritis showed  highly promising results in two late-stage clinical trials.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
277453
U.S. health officials alerted doctors on Thursday that medicines used to treat epilepsy and psychiatric disorders may raise the risk of suicidal thoughts and behavior.
600288
Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take.
727152
New developments are brewing at the pharmaceutical.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
751523
A new addition to an already successful drug promises good results for investors.